SUMO (small ubiquitin-related modifier) is a ubiquitin-like family member that is conjugated to its substrates through discrete enzymatic steps: activation, involving the E1 enzyme [SAE (SUMO-activating enzyme) 1–SAE2], conjugation, involving the E2 enzyme [Ubc9 (ubiquitin-conjugating enzyme 9)], and substrate modification, through the co-operation of Ubc9 and E3 protein ligases. Work from our laboratory has shown the first example of a viral protein, Gam1, that binds to the E1 heterodimer, inhibiting its function and causing a complete block of the SUMOylation pathway both in vivo and in vitro, followed by SAE1–SAE2 degradation. The mechanism by which a viral protein inactivates and subsequently degrades an essential cellular enzyme, arresting a key regulatory pathway, will be discussed. Although four distinct SUMO isoforms have been described, I will use SUMO to describe the entire system.
Conference Article| November 23 2007
Viral control of the SUMO pathway: Gam1, a model system
- Views Icon Views
- Share Icon Share
- Cite Icon Cite
S. Chiocca; Viral control of the SUMO pathway: Gam1, a model system. Biochem Soc Trans 1 December 2007; 35 (6): 1419–1421. doi: https://doi.org/10.1042/BST0351419
Download citation file: